Llwytho...
Prognostic and predictive value of common mutations for treatment response and survival in patients with metastatic colorectal cancer
BACKGROUND: We address the prognostic and predictive value of KRAS, PIK3CA and BRAF mutations for clinical outcomes in response to active agents in the treatment of metastatic colorectal cancer (mCRC). METHODS: We determined KRAS, BRAF and PIK3CA mutations in tumours from 168 patients treated for mC...
Wedi'i Gadw mewn:
| Prif Awduron: | , , , , , , , , , , , , , , , , , |
|---|---|
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
Nature Publishing Group
2009
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2720232/ https://ncbi.nlm.nih.gov/pubmed/19603024 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6605164 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|